Journals / Klimik Dergisi / 2016 / Cilt: 29 - Sayı: 3

Acute Generalized Exanthematous Pustulosis Due to Pyrazinamide in a Patient Receiving Antituberculous Treatment: A Case Report

Antitüberküloz Tedavi Alan Hastada Pirazinamide Bağlı Akut Jeneralize Ekzantematöz Püstüloz: Bir Olgu Sunumu

Pages
133–135
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We present here a 27-year-old patient in whom AGEP developed 3 times after the same treatment while receiving a combination of isoniazid, rifampin, ethambutol and pyrazinamide for tuberculous meningitis, in whom the causative drug was found to be pyrazinamide.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Acute generalized exanthematous pustulosis (AGEP) is a rare cutaneous eruption characterized by generalized non-follicular sterile pustules.
📊
Key Findings & Data:The most frequent causes are antibiotics, sulphonamides, and antipyretic analgesics.
💡
Conclusion & Impact:We present here a 27-year-old patient in whom AGEP developed 3 times after the same treatment while receiving a combination of isoniazid, rifampin, ethambutol and pyrazinamide for tuberculous meningitis, in whom the causative drug was found to be pyrazinamide.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Acute generalized exanthematous pustulosis (AGEP) is a rare cutaneous eruption characterized by generalized non-follicular sterile pustules. The most frequent causes are antibiotics, sulphonamides, and antipyretic analgesics. It is rarely reported to occur due to antituberculous medications. We present here a 27-year-old patient in whom AGEP developed 3 times after the same treatment while receiving a combination of isoniazid, rifampin, ethambutol and pyrazinamide for tuberculous meningitis, in whom the causative drug was found to be pyrazinamide.

Özet

Akut jeneralize ekzantematöz püstüloz (AGEP), yaygın, foliküler olmayan steril püstüllerle karakterize nadir bir kutanöz döküntüdür. Antibiyotikler, sülfonamidler, ateş düşürücü ve ağrı kesiciler bu ilaç döküntüsünün en sık nedenleridir. Nadir de olsa antitüberküloz ilaçlara karşı da oluştuğu bildirilmiştir. Bu bildiride tüberkülöz menenjit nedeniyle kombine izoniazid, rifampisin, etambutol ve pirazinamid kullanırken AGEP gelişen ve daha sonra sorumlu ilacın pirazinamid olduğu bulunan 27 yaşında bir hastayı sunduk.

🔖

Cite This Article

GÜNAL, Ö., EYİGÜN, C. P., HARMAN, R., YALÇIN, A. D., SÖKÜCÜ, M., NAMIDURU, M., YILDIRIM, E. (2022). Acute Generalized Exanthematous Pustulosis Due to Pyrazinamide in a Patient Receiving Antituberculous Treatment: A Case Report. Klimik Dergisi, Cilt: 29 - Sayı: 3, 133–135. https://ajindex.com/articles/573573

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Raviglione MC, O'Brien RJ. Tuberculosis. In: Longo DL, Fauci AS, Braunwald E, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, eds. Harrison's Principles of Internal Medicine. 18th ed. New York: McGraw-Hill, 2012: 1340-59. Akdağ R, ed. Tüberküloz Tanı ve Tedavi Rehberi. Ankara: T.C. Sağlık Bakanlığı, 2011: 63-70.
  2. Eyler JT, Squires S, Fraga GR, Liu D, Kestenbaum T. Two cases of acute generalized exanthematous pustulosis related to oral terbinafine and an analysis of the clinical reaction pattern. Der- matol Online J. 2012; 18(11): 5. Cantisani C, Paradisi A, Richetta AG, Mattozzi C, Calvieri S. Acute generalized exanthematous pustulosis during antituberculosis therapy. Clin Ter. 2013; 164(2): e137-8. Beylot C, Bioulac P, Doutre MS. Acute generalized exanthematic pustuloses (four cases). Ann Dermatol Venereol. 1980; 107(1-2): 37-48.
  3. Roujeau JC, Bioulac-Sage P, Bourseau C, et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol. 1991; 127(9): 1333-8. [CrossRef] Diaz L, Ciurea AM. Cutaneous and systemic adverse reactions to antibiotics. Dermatol Ther. 2012; 25(1): 12-22. [CrossRef] Chang SL, Huang YH, Yang CH, Hu S, Hong HS. Clinical mani- festations and characteristics of patients with acute generalized exanthematous pustulosis in Asia. Acta Derm Venereol. 2008; 88(4): 363-5.
  4. Choi MJ, Kim HS, Park HJ, et al. Clinicopathologic manifestati- ons of 36 Korean patients with acute generalized exanthema- tous pustulosis: a case series and review of the literature. Ann Dermatol. 2010; 22(2): 163-9. [CrossRef] Khayyam KU, Imam F, Sharma M, Pillai KK, Behera D. Pyrazi- namide-induced maculopapular rash. Indian J Dermatol. 2010; 55(4): 384-6. [CrossRef] Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Res- pir Crit Care Med. 2003; 167(11): 1472-7. [CrossRef] Yalcin AD. A case of netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels. Immunopharmacol Im- munotoxicol. 2016; 38(2): 162-6. [CrossRef] Yalcin AD, Karakas AA, Soykam G, et al. A case of toxic epider- mal necrolysis with diverse etiologies: successful treatment with intravenous immunoglobulin and pulse prednisolone and effects on sTRAIL and sCD200 levels. Clin Lab. 2013; 59(5-6): 681-5.